Elutia (ELUT) Cash & Equivalents Growth (1y) (2020 - 2026)
Powered by 
Analysis
Elutia (ELUT) Cash & Equivalents Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | -26.57% |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | -19.91% |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | 32.84% |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 42.78% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 0.94% |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | -11.19% |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | -3.76% |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | -4.66% |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 72.43% |
| 10 | Elutia | 34.94 Mn | 15.04 Mn | 1.45 Mn | 134.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 134.07% |
| Mar 31, 2026 | 64.12% |
| Dec 31, 2025 | 174.57% |
| Sep 30, 2025 | -81.66% |
| Jun 30, 2025 | -53.27% |
| Mar 31, 2025 | 38.30% |
| Dec 31, 2024 | -31.32% |
| Sep 30, 2024 | 77.32% |
| Jun 30, 2024 | 95.65% |
| Mar 31, 2024 | 6.46% |
| Dec 31, 2023 | 13.46% |
| Sep 30, 2023 | 79.20% |
| Jun 30, 2023 | -43.62% |
| Mar 31, 2023 | -46.57% |
| Dec 31, 2022 | -44.10% |
| Sep 30, 2022 | -64.06% |
| Jun 30, 2022 | -41.74% |
| Mar 31, 2022 | -27.44% |
| Dec 31, 2021 | -22.37% |
| Sep 30, 2021 | 1,360.04% |